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sented, important topic. This area is obviously crying out for
some standardization and guidance, as it has been for the last
20 years, unfortunately. Do all your patients who undergo cath-
eter-directed thrombolysis go to the intensive care unit (ICU)
for monitoring, or do you have an intermediate stepdown area
for monitoring patients receiving thrombolytic therapy in a
lower-cost environment?
Dr Fedor Lurie. In the four hospitals included in the study,
all the patients go to the ICU. The cost of the interventional
unit was added to the ICU cost.
Dr Dalman. Because there are other options. I don’t know
that every patient needs to be in the ICU when they are receiving
catheter-directed thrombolysis.
So for the average patient now, based on these data, has this
changed your practice at all for the nonembolic acute limb
ischemia patients? Have you used these data to change your prac-
tice, or how are you currently managing those patients?
Dr Lurie. That is a key question. The data itself do not guide
us to change any speciﬁc aspect of our practice except to look at
the administrative policies that can affect the ICU stay, such as
inability to transfer patients from the ICU at certain times.
Dr Peter Henke (Ann Arbor, Mich). I agree with Ron, this
is really understudied and needs standardization, as was
mentioned.
But nonembolic acute limb ischemia can occur from a variety
of different etiologies. Can you give us an idea of what some of
those were. Were they just all acute-on-chronic peripheral arterial
disease (PAD), for example, or trauma, dissection, those type of
things? Because that may affect the management choice.Dr Lurie. One of the reasons we selected to study the patient
population that we have an access to the medical records was to
carefully select speciﬁc etiology. The majority of those patients
had a thrombotic ischemia, except ﬁve who had iatrogenic throm-
bosis. Twenty-one patients with thrombosis of a native artery had
clinical manifestation of PAD prior to acute ischemia, and 90 pa-
tients had thrombosis of a bypass graft. So I would think that
the results are mostly applicable for thrombotic ischemia in pa-
tients with or without PAD.
Dr John Blebea (Tulsa, Okla). Encompassing a multitude of
patients at four different hospitals, were you able to analyze and
deﬁne the selection of patients, and speciﬁcally, how was it decided
that these patients underwent surgery vs endovascular interven-
tions? Secondly, did you examine outcomes based on experience
or speciality of the physician for these procedures?
Dr Lurie. To address the second part, we did not do an anal-
ysis per provider. We can, but then we will end up with very small
numbers that will be unlikely meaningful.
Addressing the ﬁrst part of this question, I would like to
emphasize that the focus of this study is to look at what is
happening actually in the community settings. Patient selection
and decisions of which treatment modality to use as the initial op-
tion was done by community practitioners in the absence of insti-
tutional guidelines. The overall clinical outcomes were good. So
one can suspect that the selection of patients was appropriate.
One factor that I can tell you that we looked at, for example,
in the subgroup of patients with occluded grafts, thrombolysis was
used more frequently than other options, which is in line with the
recommendations of the Surgery vs Thrombolysis for Ischemia of
the Lower Extremity (STILE) trial.
